Global Newborn and Prenatal Genetic Testing Market
Description
MARKET SCOPE:
The global Newborn and Prenatal Genetic Testing market is projected to grow significantly, registering a CAGR of 11.5% during the forecast period (2024 – 2032).
Prenatal testing is a crucial aspect of monitoring your baby's health, aiming to identify any potential issues that might impact the well-being of the fetus, including genetic defects and congenital conditions. While some prenatal tests are recommended by doctors, only a select group of women may require specialized screening examinations. Concurrently, newborn testing is conducted to identify abnormalities that could lead to specific health conditions, particularly inborn genetic defects. The screening process for genetic diseases in newborns encompasses conditions such as Down syndrome, phenylketonuria, homocystinuria, among others. Consequently, the early diagnosis of genetic diseases during pregnancy and within the initial 24 hours of a newborn's birth holds significant importance.
Prenatal genetic testing is conducted during pregnancy to diagnose diseases or detect specific genetic abnormalities, typically before the 8 to 10 weeks of gestation, and it aids in determining the fetus's gender. The majority of prenatal genetic tests utilize a blood sample from the expectant mother for various screening procedures. Diagnostic methods, known for their higher effectiveness and accuracy, are the preferred choice for detecting chromosome abnormalities compared to screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to factors such as the rising prevalence of genetic diseases among infants, governmental support promoting the use of prenatal and newborn testing, and an increase in birth rates.
MARKET OVERVIEW:
Driver: High number of genetic diseases patients in infants is driving the market growth.
The increased occurrence of genetic diseases in infants has contributed significantly to the expansion of the prenatal testing and newborn screening market. As per the World Health Organization's classification, genetic diseases encompass various conditions like Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, for instance, affects millions worldwide and is notably prevalent among individuals with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. A report from November 2021, as per the National Center for Biotechnology Information, revealed that genetic illnesses were identified in 9.4% of pediatric patients, with 44.7% of these cases observed in critically ill newborns. This heightened prevalence of genetic diseases in infants has spurred the demand, contributing to the growth of the prenatal testing and newborn screening market.
Opportunities: Rising birth rate globally is expected to pave the way for market growth in the upcoming years.
The upsurge in the birth rate is anticipated to drive the expansion of the prenatal testing and newborn screening market. The birth rate, or natality, denotes the total number of live human births per 1,000 population within a specific period, divided by the length of that period in years. Prenatal testing plays a crucial role in evaluating fetal health before birth, while newborn screening tests identify certain medical conditions in infants shortly after birth, facilitating early intervention if necessary. For example, in May 2022, as reported by the Centers for Disease Control and Prevention, a US-based national public health agency, there was a 1% increase in births in 2021, totaling 3,659,289. The general fertility rate reached 56.6 births per 1,000 women aged 15-44, reflecting a 1% rise from the figures in 2020. Consequently, the surge in the birth rate contributes to the overall growth of the prenatal testing and newborn screening market.
COVID IMPACT:
The onset of the COVID-19 pandemic has caused significant disruptions in healthcare workflows worldwide. The disease has compelled numerous industries, including various healthcare sub-domains, to temporarily suspend operations. The global prenatal and newborn genetic testing market faced a downturn in 2020 due to the global economic downturn triggered by COVID-19. Furthermore, the pandemic disrupted the supply chain across diverse end-user industries, including healthcare, food & beverage, and industrial sectors. However, the market is expected to undergo recovery in 2021, displaying steady growth in the prenatal and newborn genetic testing market in the foreseeable future. This rebound is credited to the increased adoption of novel screening methods, particularly in developing countries such as China and India.
SEGMENTATION ANALYSIS:
The consumable segment is anticipated to grow significantly during the forecast period.
The consumables segment held the largest market share in Prenatal and Newborn Genetic Testing, driven by an increase in the number of pregnant women and a surge in newborn screening for genetic testing. Notably, approximately 4 million babies undergo screening annually in the U.S., as reported by Healthy Moms. Strong Babies. On the other hand, the diagnostic segment is experiencing the fastest growth during the forecast period, propelled by the growing adoption of prenatal and newborn testing in developing countries.
The hospital segment is anticipated to grow significantly during the forecast period.
In 2022, the hospital segment secured the largest market share, attributed to the presence of qualified medical staff, enabling enhanced services for patients, particularly in the diagnosis and treatment of neuromuscular diseases, including genetic abnormalities. Hospitals play a pivotal role in delivering superior patient services. Conversely, diagnostic centers are projected to exhibit the highest growth rate in the forecast period. This is primarily due to these centers offering comprehensive pre-pregnancy and prenatal services, reducing the potential for complications during pregnancy.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
In 2022, North America emerged as the frontrunner in the prenatal and newborn genetic testing market and is expected to sustain its leadership throughout the forecast period. This is attributed to the robust presence of major players like Abbott Laboratories, PerkinElmer Inc., and Mettler Toledo, coupled with advancements in PCR diagnostic methods. The market in this region is further fueled by the growing number of expectant women opting for genetic screening. Additionally, factors such as high purchasing power and increasing awareness about various inherited genetic diseases are poised to propel market growth. Notably, World Down Syndrome Day is annually observed on March 21, aiming to raise awareness about the diagnosis and treatment of individuals with Down syndrome.
COMPETITIVE ANALYSIS
The global Newborn and Prenatal Genetic Testing market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
BGI Group
Abbott Laboratories
Quest Diagnostics Incorporated
Mettler Toledo
Laboratory Corporation of America Holdings
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Natera, Inc.
Thermo Fisher Scientific Inc.
SCOPE OF THE REPORT
By Product Type
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Newborn and Prenatal Genetic Testing market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Newborn and Prenatal Genetic Testing submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
The global Newborn and Prenatal Genetic Testing market is projected to grow significantly, registering a CAGR of 11.5% during the forecast period (2024 – 2032).
Prenatal testing is a crucial aspect of monitoring your baby's health, aiming to identify any potential issues that might impact the well-being of the fetus, including genetic defects and congenital conditions. While some prenatal tests are recommended by doctors, only a select group of women may require specialized screening examinations. Concurrently, newborn testing is conducted to identify abnormalities that could lead to specific health conditions, particularly inborn genetic defects. The screening process for genetic diseases in newborns encompasses conditions such as Down syndrome, phenylketonuria, homocystinuria, among others. Consequently, the early diagnosis of genetic diseases during pregnancy and within the initial 24 hours of a newborn's birth holds significant importance.
Prenatal genetic testing is conducted during pregnancy to diagnose diseases or detect specific genetic abnormalities, typically before the 8 to 10 weeks of gestation, and it aids in determining the fetus's gender. The majority of prenatal genetic tests utilize a blood sample from the expectant mother for various screening procedures. Diagnostic methods, known for their higher effectiveness and accuracy, are the preferred choice for detecting chromosome abnormalities compared to screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to factors such as the rising prevalence of genetic diseases among infants, governmental support promoting the use of prenatal and newborn testing, and an increase in birth rates.
MARKET OVERVIEW:
Driver: High number of genetic diseases patients in infants is driving the market growth.
The increased occurrence of genetic diseases in infants has contributed significantly to the expansion of the prenatal testing and newborn screening market. As per the World Health Organization's classification, genetic diseases encompass various conditions like Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia, for instance, affects millions worldwide and is notably prevalent among individuals with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. A report from November 2021, as per the National Center for Biotechnology Information, revealed that genetic illnesses were identified in 9.4% of pediatric patients, with 44.7% of these cases observed in critically ill newborns. This heightened prevalence of genetic diseases in infants has spurred the demand, contributing to the growth of the prenatal testing and newborn screening market.
Opportunities: Rising birth rate globally is expected to pave the way for market growth in the upcoming years.
The upsurge in the birth rate is anticipated to drive the expansion of the prenatal testing and newborn screening market. The birth rate, or natality, denotes the total number of live human births per 1,000 population within a specific period, divided by the length of that period in years. Prenatal testing plays a crucial role in evaluating fetal health before birth, while newborn screening tests identify certain medical conditions in infants shortly after birth, facilitating early intervention if necessary. For example, in May 2022, as reported by the Centers for Disease Control and Prevention, a US-based national public health agency, there was a 1% increase in births in 2021, totaling 3,659,289. The general fertility rate reached 56.6 births per 1,000 women aged 15-44, reflecting a 1% rise from the figures in 2020. Consequently, the surge in the birth rate contributes to the overall growth of the prenatal testing and newborn screening market.
COVID IMPACT:
The onset of the COVID-19 pandemic has caused significant disruptions in healthcare workflows worldwide. The disease has compelled numerous industries, including various healthcare sub-domains, to temporarily suspend operations. The global prenatal and newborn genetic testing market faced a downturn in 2020 due to the global economic downturn triggered by COVID-19. Furthermore, the pandemic disrupted the supply chain across diverse end-user industries, including healthcare, food & beverage, and industrial sectors. However, the market is expected to undergo recovery in 2021, displaying steady growth in the prenatal and newborn genetic testing market in the foreseeable future. This rebound is credited to the increased adoption of novel screening methods, particularly in developing countries such as China and India.
SEGMENTATION ANALYSIS:
The consumable segment is anticipated to grow significantly during the forecast period.
The consumables segment held the largest market share in Prenatal and Newborn Genetic Testing, driven by an increase in the number of pregnant women and a surge in newborn screening for genetic testing. Notably, approximately 4 million babies undergo screening annually in the U.S., as reported by Healthy Moms. Strong Babies. On the other hand, the diagnostic segment is experiencing the fastest growth during the forecast period, propelled by the growing adoption of prenatal and newborn testing in developing countries.
The hospital segment is anticipated to grow significantly during the forecast period.
In 2022, the hospital segment secured the largest market share, attributed to the presence of qualified medical staff, enabling enhanced services for patients, particularly in the diagnosis and treatment of neuromuscular diseases, including genetic abnormalities. Hospitals play a pivotal role in delivering superior patient services. Conversely, diagnostic centers are projected to exhibit the highest growth rate in the forecast period. This is primarily due to these centers offering comprehensive pre-pregnancy and prenatal services, reducing the potential for complications during pregnancy.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
In 2022, North America emerged as the frontrunner in the prenatal and newborn genetic testing market and is expected to sustain its leadership throughout the forecast period. This is attributed to the robust presence of major players like Abbott Laboratories, PerkinElmer Inc., and Mettler Toledo, coupled with advancements in PCR diagnostic methods. The market in this region is further fueled by the growing number of expectant women opting for genetic screening. Additionally, factors such as high purchasing power and increasing awareness about various inherited genetic diseases are poised to propel market growth. Notably, World Down Syndrome Day is annually observed on March 21, aiming to raise awareness about the diagnosis and treatment of individuals with Down syndrome.
COMPETITIVE ANALYSIS
The global Newborn and Prenatal Genetic Testing market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
BGI Group
- In June 2019, BGI Genomics and Eluthia collaborated to introduce a non-invasive prenatal test in Germany, offering prenatal diagnosis for 96 genetic conditions. This expansion into the German market played a pivotal role in boosting the sales of the product for the company.
Abbott Laboratories
Quest Diagnostics Incorporated
Mettler Toledo
Laboratory Corporation of America Holdings
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Natera, Inc.
Thermo Fisher Scientific Inc.
SCOPE OF THE REPORT
By Product Type
- Consumables
- Instruments
- Non-invasive Prenatal Testing
- Chronic Villus Sampling
- Amniocentesis
- Maternal Serum Screening
- Others
- Downs Syndrome
- Phenylketonuria
- Cystic Fibrosis
- Sickle Cell Anemia
- Others
- Hospital
- Maternity and Specialty Clinics
- Diagnostic centers
- North America (the United States & Canada)
- Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
- Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
- Rest of the World (the Middle East & Africa, and Latin America)
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Newborn and Prenatal Genetic Testing market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Newborn and Prenatal Genetic Testing submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
Table of Contents
198 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Regional Analysis
- 1.3. Segment Analysis
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Newborn And Prenatal Genetic Testing Market Overview By Region: 2019 Vs 2023 Vs 2032
- 3.1. Global Newborn And Prenatal Genetic Testing Market Size By Regions (2019-2023) (Usd Million)
- 3.1.1. North America Newborn And Prenatal Genetic Testing Market Size By Country (2019-2023) (Usd Million)
- 3.1.2. Europe Newborn And Prenatal Genetic Testing Market Size By Country (2019-2023) (Usd Million)
- 3.1.3. Asia Pacific America Newborn And Prenatal Genetic Testing Market Size By Country (2019-2023) (Usd Million)
- 3.1.4. Rest Of The World Newborn And Prenatal Genetic Testing Market Size By Country (2019-2023) (Usd Million)
- 3.2. Global Newborn And Prenatal Genetic Testing Market Size By Regions (2024-2032) (Usd Million)
- 3.2.1. North America Newborn And Prenatal Genetic Testing Market Size By Country (2024-2032) (Usd Million)
- 3.2.2. Europe Newborn And Prenatal Genetic Testing Market Size By Country (2024-2032) (Usd Million)
- 3.2.3. Asia Pacific Newborn And Prenatal Genetic Testing Market Size By Country (2024-2032) (Usd Million)
- 3.2.4. Rest Of The World Newborn And Prenatal Genetic Testing Market Size By Country (2024-2032) (Usd Million)
- 4. Global Newborn And Prenatal Genetic Testing Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.3. Market Opportunities
- 4.2. Pestle Analysis
- 4.3. Porter’s Five Forces Model
- 4.3.1. Bargaining Power Of Suppliers
- 4.3.2. Bargaining Power Of Buyers
- 4.3.3. The Threat Of New Entrants
- 4.3.4. Threat Of Substitutes
- 4.3.5. Intensity Of Rivalry
- 4.4. Value Chain Analysis/Supply Chain Analysis
- 4.5. Covid-19 Impact Analysis On Global Newborn And Prenatal Genetic Testing Market
- ** In – Depth Qualitative Analysis Will Be Provided In The Final Report Subject To Market
- 5. Global Newborn And Prenatal Genetic Testing Market, By Product Type
- 5.1. Overview
- 5.2. Global Newborn And Prenatal Genetic Testing Market Size By Product Type
- 5.3. Key Findings For Newborn And Prenatal Genetic Testing Market - By Product Type
- 5.3.1. Consumables
- 5.3.2. Instruments
- 6. Global Newborn And Prenatal Genetic Testing Market, By Screening
- 6.1. Overview
- 6.2. Key Findings For Newborn And Prenatal Genetic Testing Market - By Screening
- 6.2.1. Non-invasive Prenatal Testing
- 6.2.2. Chronic Villus Sampling
- 6.2.3. Amniocentesis
- 6.2.4. Maternal Serum Screening
- 6.2.5. Others
- 7. Global Newborn And Prenatal Genetic Testing Market, By Disease
- 7.1. Overview
- 7.2. Key Findings For Newborn And Prenatal Genetic Testing Market - By Disease
- 7.2.1. Downs Syndrome
- 7.2.2. Phenylketonuria
- 7.2.3. Cystic Fibrosis
- 7.2.4. Sickle Cell Anemia
- 7.2.5. Others
- 8. Global Newborn And Prenatal Genetic Testing Market, By End Users
- 8.1. Overview
- 8.2. Key Findings For Newborn And Prenatal Genetic Testing Market - By End Users
- 8.2.1. Hospital
- 8.2.2. Maternity And Specialty Clinics
- 8.2.3. Diagnostic Centers
- 9. Global Newborn And Prenatal Genetic Testing Market, By Region
- 9.1. Overview
- 9.2. Key Findings For Newborn And Prenatal Genetic Testing Market- By Region
- 9.3. Global Newborn And Prenatal Genetic Testing Market, By Product Type
- 9.4. Global Newborn And Prenatal Genetic Testing Market, By Screening
- 9.5. Global Newborn And Prenatal Genetic Testing Market, By Disease
- 9.6. Global Newborn And Prenatal Genetic Testing Market, By End Users
- 10. Global Newborn And Prenatal Genetic Testing Market- North America
- 10.1. Overview
- 10.2. North America Newborn And Prenatal Genetic Testing Market Size (2019 - 2032) (Usd Million)
- 10.3. North America Newborn And Prenatal Genetic Testing Market, By Product Type
- 10.4. North America Newborn And Prenatal Genetic Testing Market, By Screening
- 10.5. North America Newborn And Prenatal Genetic Testing Market, By Disease
- 10.6. North America Newborn And Prenatal Genetic Testing Market, By End Users
- 10.7. North America Newborn And Prenatal Genetic Testing Market Size By Countries
- 10.7.1. United States
- 10.7.2. Canada
- 11. Global Newborn And Prenatal Genetic Testing Market- Europe
- 11.1. Overview
- 11.2. Europe Newborn And Prenatal Genetic Testing Market Size (2019 - 2032) (Usd Million)
- 11.3. Europe Newborn And Prenatal Genetic Testing Market, By Product Type
- 11.4. Europe Newborn And Prenatal Genetic Testing Market, By Screening
- 11.5. Europe Newborn And Prenatal Genetic Testing Market, By Disease
- 11.6. Europe Newborn And Prenatal Genetic Testing Market, By End Users
- 11.7. Europe Newborn And Prenatal Genetic Testing Market Size By Countries
- 11.7.1. Germany
- 11.7.2. Uk
- 11.7.3. France
- 11.7.4. Spain
- 11.7.5. Italy
- 11.7.6. Rest Of Europe
- 12. Global Newborn And Prenatal Genetic Testing Market - Asia Pacific
- 12.1. Overview
- 12.2. Asia Pacific Newborn And Prenatal Genetic Testing Market Size (2019 - 2032) (Usd Million)
- 12.3. Asia Pacific Newborn And Prenatal Genetic Testing Market, By Product Type
- 12.4. Asia Pacific Newborn And Prenatal Genetic Testing Market, By Screening
- 12.5. Asia Pacific Newborn And Prenatal Genetic Testing Market, By Disease
- 12.6. Asia Pacific Newborn And Prenatal Genetic Testing Market, By End Users
- 12.7. Asia Pacific Newborn And Prenatal Genetic Testing Market Size By Countries
- 12.7.1. China
- 12.7.2. Japan
- 12.7.3. India
- 12.7.4. Rest Of Asia Pacific
- 13. Global Newborn And Prenatal Genetic Testing Market- Rest Of World
- 13.1. Overview
- 13.2. Rest Of World Newborn And Prenatal Genetic Testing Market Size (2019 - 2032) (Usd Million)
- 13.3. Rest Of World Newborn And Prenatal Genetic Testing Market, By Product Type
- 13.4. Rest Of World Newborn And Prenatal Genetic Testing Market, By Screening
- 13.5. Rest Of World Newborn And Prenatal Genetic Testing Market, By Disease
- 13.6. Rest Of World Newborn And Prenatal Genetic Testing Market, By End Users
- 13.7. Rest Of World Newborn And Prenatal Genetic Testing Market Size By Regions
- 13.7.1. Middle East & Africa
- 13.7.2. Latin America
- 14. Global Newborn And Prenatal Genetic Testing Market- Competitive Landscape
- 14.1. Key Strategies Adopted By The Leading Players
- 14.2. Recent Developments
- 14.2.1. Investments & Expansions
- 14.2.2. New End-user Launches
- 14.2.3. Mergers & Acquisitions
- 14.2.4. Agreements, Joint Ventures, And Partnerships
- 15. Global Newborn And Prenatal Genetic Testing Market- Company Profiles
- 15.1. Bgi Group
- 15.1.1. Company Overview
- 15.1.2. Financial Overview
- 15.1.3. Product Offered
- 15.1.4. Key Developments
- 15.2. F. Hoffmann-la Roche Ag
- 15.3. Abbott Laboratories
- 15.4. Quest Diagnostics Incorporated
- 15.5. Mettler Toledo
- 15.6. Laboratory Corporation Of America Holdings
- 15.7. Bio-rad Laboratories, Inc.
- 15.8. Perkinelmer Inc.
- 15.9. Natera, Inc.
- 15.10. Thermo Fisher Scientific Inc.
- 16. Our Research Methodology
- 16.1. Data Triangulation
- 16.2. Data Sources
- 16.2.1. Secondary Sources
- 16.2.2. Primary Sources
- 16.3. Assumptions/ Limitations For The Study
- 16.4. Research & Forecasting Methodology
- 17. Appendix
- 17.1. Disclaimer
- 17.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
